ストックスクリーナーアプリを入手
10.76
0.92%
-0.10
アフターアワーズ：
10.95
0.19
+1.77%
Kura Oncology Inc (KURA) 最新ニュース
Kura Oncology CSO Francis Burrows Executes Stock Option and Sells Shares in September 2026 - Kalkine Media
After exercising options, Kura Oncology (KURA) science chief sold 20,726 shares to cover estimated payroll taxes. - Stock Titan
Form 144 KURA ONCOLOGY For: 25 September By Investing.com - Investing.com South Africa
Shares from a stock option exercise are proposed for sale by a Kura Oncology (KURA) officer, valued at $224,514. - Stock Titan
Why (KURA) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Kura Oncology stock holds at USD 11.73 as Caspian launches - ad-hoc-news.de
Kura Oncology, Inc. (KURA) Stock Analysis: A Biotech Innovator with a 173% Potential Upside - DirectorsTalk Interviews
KURA News | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
Kura Oncology to present at three investor conferences in September - scanx.trade
Kura Oncology Q2 2026 Earnings Call Transcript - Benzinga
Kura Oncology at Morgan Stanley conference: early sales, bigger bets By Investing.com - Investing.com Nigeria
Kura Oncology at Morgan Stanley conference: early sales, bigger bets - Investing.com
Kura Oncology (KURA) awards CFO 450,000 stock options - Stock Titan
Kura Oncology (KURA) CFO files initial ownership report with no trades - Stock Titan
Kura Oncology Maintains 49.2% Stake in Caspian Therapeutics Following $50M Series A Funding - Kalkine Media
symbol__ Stock Quote Price and Forecast - CNN
Kura Spins Out Caspian With $50m To Test Menin Inhibition In Diabetes - insights.citeline.com
Kura assets flow to Caspian for cardiometabolic indications - BioWorld News
Kura Oncology Pivots Diabetes Strategy Into $50 Million Subsidiary - AOL.com
Kura Oncology Raises $50M for Cardiometabolic Subsidiary Caspian - minichart.com.sg
KURA Oncology Launches Caspian Therapeutics, Shifting Focus Whil - GuruFocus
Kura Oncology at cantor conference: rapid launch, wider ambitions - Investing.com India
Kura Oncology at cantor conference: rapid launch, wider ambitions By Investing.com - Investing.com Canada
Kura Oncology, Inc. Enters into Contribution and License and Intercompany Services Agreement with Caspian Therapeutics, Inc - marketscreener.com
Kura Oncology Launches Caspian Therapeutics With $50 Million Funding - marketscreener.com
Kura Oncology Appoints Jennifer Fulk as New CFO - The Globe and Mail
Kura Oncology Establishes Caspian Partnership for Cardiometabolic Focus - TipRanks
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes - The Manila Times
Eli Lilly is among investors in a new diabetes company with $50 million - Stock Titan
Kura Oncology spins out diabetes pipeline with $50M and Lilly’s help - Endpoints News
KURA: Strong commercial momentum and advancing late-stage pipeline position for major growth - TradingView
KURA: Strong commercial momentum and advancing late-stage pipeline position for major growth by 2028 - TradingView
Kura Oncology at Wells Fargo conference: launch gains and pipeline breadth - investing.com
Kura Oncology Names Jennifer Fulk as Chief Financial Officer Effective September 8, 2026 - Kalkine Media
Kura Oncology Names Jennifer Fulk Chief Financial Officer - Minichart
Kura Oncology, Inc. Announces Chief Financial Officer Changes, Effective September 8, 2026 - marketscreener.com
Kura Oncology Names Jennifer Fulk Finance Chief - marketscreener.com
Jennifer Fulk named CFO of Kura Oncology, replacing Troy E. Wilson and Thomas Doyle - TradingView
New Kura Oncology (KURA) CFO gets 450,000 options and up to 18 months of severance pay - Stock Titan
A former Eli Lilly executive takes Kura's top finance job - Stock Titan
Four new hires get options to buy 48,450 Kura shares - Stock Titan
Price-Driven Insight from (KURA) for Rule-Based Strategy - Stock Traders Daily
Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run - finance.yahoo.com
KURA Stock Gains 37.6% in a Month: Here's What You Need to Know - TradingView
Kura Oncology to Participate in Three Investor Conferences in September - GlobeNewswire
Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Cancer Biotech Kura Oncology Rallies to New High After CEO’s Stock Purchase - Barron's
Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last? - qz.com
Kura Oncology: 'Strong Buy': Ziftomenib AML Expansions With Different Regimens Could Boost KOMZIFTI's Prospects - Seeking Alpha
Kura Oncology Shares Rise After CEO Purchases 100,000 Shares - marketscreener.com
Kura Oncology stock jumps after CEO buys $1.24M in shares - Investing.com Nigeria
Kura Oncology CCO Brian Powl sells $51,663 in shares By Investing.com - Investing.com India
Kura Oncology CEO Troy Wilson buys $1.24 million Kura shares By Investing.com - Investing.com South Africa
Citizens reiterates Kura Oncology stock rating on launch progress - Investing.com
UBS Remains a Buy on Kura Oncology (KURA) - The Globe and Mail
Kura Oncology (KURA) Chief Legal Officer Teresa Bair Sells 31,48 - GuruFocus
Kura Oncology (NASDAQ:KURA) Insider Sells 31,487 Shares - MarketBeat
Kura Oncology (NASDAQ: KURA) affiliate flags 4,345-share Rule 144 sale - Stock Titan
Kura Oncology (KURA) counsel offloads shares via 10b5-1 plan - Stock Titan
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):